While Williams said she put a lot of thought into taking anti-obesity medication, she told Vogue that at this point in her life, she doesnt feel ashamed about letting the public know
Danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist, will undergo dose optimization studies in the second half of 2024 as Pfizer seeks to evaluate multiple doses of the formulation which they hope will inform the registration-enabling studies
Theyre available at suspicious-looking med spas and the long-term effects, particularly around withdrawal, are not completely understood yet
Still, the compound market has grown persistently to new heights, with adjacent companies targeting the broader weight loss space in healthcare, as patient demand for GLP-1 medications continues to rise
Less than a year later, over a hundred million mRNA vaccine doses had been produced and distributed
At Calla Genics, our team is committed to helping clients shed hard-to-lose weight so they can experience the joys of life long after retirement